Alnylam Archives - Pharmaphorum

NICE restores parity between Alnylam and Akcea on rare disease

https://pharmaphorum.com/news/nice-restores-parity-between-alnylam-and-akcea-on-rare-disease/

https://pharmaphorum.com/news/nice-backs-akceas-tegsedi-pipping-alnylam-to-hattr-okay/

Alnylam to file gene-silencing porphyria drug

https://pharmaphorum.com/news/alnylam-to-file-gene-silencing-porphyria-drug/

R&D Roundup: Pharma gets in on the biotech boom

https://pharmaphorum.com/r-d/views-analysis-r-d/rd-roundup-pharma-gets-in-on-the-biotech-boom/

Regeneron and Alnylam announce $1bn collaboration

https://pharmaphorum.com/news/regeneron-and-alnylam-announce-1bn-collaboration/

Sanofi and Alnylam conclude research phase of RNAi alliance

https://pharmaphorum.com/news/sanofi-and-alnylam-conclude-research-phase-of-rnai-alliance/

FDA approves Ionis/Akcea’s Tegsedi RNAi drug, taking on Alnylam

https://pharmaphorum.com/news/fda-approves-ionis-akceas-tegsedi-competing-against-alnylam/

Alnylam rare disease drug may be delayed

https://pharmaphorum.com/news/alnylam-rare-disease-drug-may-be-delayed/

Alnylam’s Onpattro is first ever FDA-approved RNAi drug

https://pharmaphorum.com/news/alnylams-onpattro-first-ever-approved-rnai-drug/

Search